Literature DB >> 10637429

Structure, function and regulation of p63 and p73.

M Levrero1, V De Laurenzi, A Costanzo, J Gong, G Melino, J Y Wang.   

Abstract

The p53 tumor suppressor gene is one of the most frequently mutated genes in human cancers.1 p53 is a sequence-specific transcription factor and plays a critical role in activating the expression of genes involved in cell cycle arrest or apoptosis under conditions of genotoxic stress.2,3 For over two decades, p53 was thought to be the only gene of its kind in the vertebrate genomes. This strong conviction, which was widely accepted in the p53 field, has now been proven to be incorrect. Two genes, referred to as p63 and p73, have been found to encode proteins that share a significant amino-acid identity in the transactivation domain, the DNA binding domain, and the oligomerization domain with p53. In the short period since their cloning, a number of investigators have reported on the structure, the function and the regulation of p63 and p73. This review summarizes the current information on the p63 and the p73 genes, with a focus on the differences between the three members in this newly defined p53-gene family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10637429     DOI: 10.1038/sj.cdd.4400624

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  23 in total

1.  Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase.

Authors:  Christian Melle; Heinz-Peter Nasheuer
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

2.  The human p73 promoter: characterization and identification of functional E2F binding sites.

Authors:  Ratnam S Seelan; Meredith Irwin; Petra van der Stoop; Chiping Qian; William G Kaelin; Wanguo Liu
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

3.  The emerging role of matrix metalloproteases of the ADAM family in male germ cell apoptosis.

Authors:  Ricardo D Moreno; Paulina Urriola-Muñoz; Raúl Lagos-Cabré
Journal:  Spermatogenesis       Date:  2011-07-01

4.  Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.

Authors:  R Scott Stephens; Laura E Servinsky; Otgonchimeg Rentsendorj; Todd M Kolb; Alexander Pfeifer; David B Pearse
Journal:  Am J Physiol Cell Physiol       Date:  2014-01-08       Impact factor: 4.249

5.  Association of p73 gene G4C14-A4T14 polymorphism and MDM2 gene SNP309 with non-small cell lung cancer risk in a Chinese population.

Authors:  Wen Li; Shuang Shuang Wang; Jing Deng; Jian Xin Tang
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

6.  p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.

Authors:  Shohreh Amini; Giuseppe Mameli; Luis Del Valle; Anna Skowronska; Krzysztof Reiss; Benjamin B Gelman; Martyn K White; Kamel Khalili; Bassel E Sawaya
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  The Roles of P53 and Its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis-Stage Mouse Embryos.

Authors:  Nazem El Husseini; Barbara F Hales
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

8.  PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.

Authors:  Eliana Munarriz; Daniela Barcaroli; Anastasis Stephanou; Paul A Townsend; Carine Maisse; Alessandro Terrinoni; Michael H Neale; Seamus J Martin; David S Latchman; Richard A Knight; Gerry Melino; Vincenzo De Laurenzi
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein.

Authors:  P A Hall; A C Woodman; S J Campbell; N A Shepherd
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

10.  Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.

Authors:  Hidetaka Uramoto; Hiroto Izumi; Gunji Nagatani; Haruki Ohmori; Naofumi Nagasue; Tomoko Ise; Takeshi Yoshida; Kosei Yasumoto; Kimitoshi Kohno
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.